James Karrels

This profile gathers the share dealings of James Karrels in Macrogenics Inc, where the filings describe the role as finance chief. The record holds 9 filings, for trades running from 29 January 2016 to 15 February 2026.

The open-market side counts 1 purchase for €94k alongside 1 sale for €567k. Taken together, the sales exceed the purchases by €473k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 7 option exercises.

The latest filing, published on 17 February 2026, reports an option exercise in Macrogenics Inc. The clock since the last published purchase (17 June 2022) now reads 1,584 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.